These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29671165)

  • 1. Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.
    Sundquist K; Ahmad A; Svensson PJ; Zöller B; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2018 Aug; 46(2):154-165. PubMed ID: 29671165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
    Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
    Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
    Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.
    Ahmad A; Memon AA; Sundquist J; Svensson PJ; Zöller B; Sundquist K
    Gene; 2018 Mar; 647():136-142. PubMed ID: 29325734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies.
    Eroglu A; Sertkaya Karasoy D; Eroglu N; Akar N
    J BUON; 2008; 13(1):61-4. PubMed ID: 18404788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2016 Jul; 42(1):135-41. PubMed ID: 26743062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2017 Jul; 44(1):130-138. PubMed ID: 28321710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific risk factors for recurrent venous thromboembolism.
    Olié V; Zhu T; Martinez I; Scarabin PY; Emmerich J
    Thromb Res; 2012 Jul; 130(1):16-20. PubMed ID: 22100316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
    Moussaoui S; Saussoy P; Ambroise J; Defour JP; Zouitene R; Sifi K; Abadi N
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):105-115. PubMed ID: 26304686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide association study in the genetic analysis of idiopathic thrombophilia project suggests sex-specific regulation of mitochondrial DNA levels.
    López S; Buil A; Souto JC; Casademont J; Martinez-Perez A; Almasy L; Soria JM
    Mitochondrion; 2014 Sep; 18():34-40. PubMed ID: 25240745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):319-328. PubMed ID: 28049360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
    Sundquist K; Sundquist J; Svensson PJ; Zöller B; Memon AA
    J Thromb Haemost; 2015 Dec; 13(12):2180-6. PubMed ID: 26407905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2011 Jan; 13(1):67-76. PubMed ID: 21150787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
    Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Svensson PJ; Sundquist J; Memon AA
    Thromb Haemost; 2016 Aug; 116(3):432-41. PubMed ID: 27277397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden paradox in a middle-aged Swedish population: A prospective study.
    Zöller B; Melander O; Svensson PJ; Engström G
    Vasc Med; 2018 Feb; 23(1):52-59. PubMed ID: 29320959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.
    Ahmad A; Sundquist K; Palmér K; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2019 Feb; 47(2):216-226. PubMed ID: 30368761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
    Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.